Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 107

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 4
Chunk 107
---
Item 4. Information on the Company.

  History and Development of the Company  
 ──────────────────────────────────────────

Our legal name is Alpha Tau
Medical Ltd. and our commercial name is Alpha Tau.

We were founded in November
2015 by Uzi Sofer, our Chief Executive Officer and Chairman, along with the inventors of the Alpha DaRT®technology including
Professor Itzhak Kelson and Professor Yona Keisari of Tel Aviv University, our Chief Physics Officer and Chief Scientific Officer, respectively.
Together, they founded Alpha Tau with the goal of bringing this innovative technology out of the laboratory and into patients, in order
to bring hope to cancer patients around the world. We are registered with the Israeli Registrar of Companies. Our registration number
is 51-534453-9.

The main address of our principal
executive offices is 5 Kiryat HaMada St., Jerusalem, Israel 9777605 and our telephone number is +972 (3) 577-4115. Our agent for service
of process in the United States is Alpha Tau Medical, Inc., 1 Union Street 3rd Floor, Lawrence, MA 01840.

For a description of our principal
capital expenditures and divestitures for the three years ended December 31, 2024 and for those currently in progress, see Item 5. “ Operating
and Financial Review and Prospects.”

On July 7, 2021, we entered
into the Merger Agreement with HCCC and Merger Sub. Pursuant to the Merger Agreement, Merger Sub merged with and into HCCC, with HCCC
surviving the merger. Upon consummation of the Business Combination and the other transactions contemplated by the Merger Agreement on
March 7, 2022, HCCC became a wholly owned subsidiary of Alpha Tau. In July 2022, we took the necessary actions to dissolve HCCC.

The SEC maintains an Internet
site that contains reports, proxy and information statements, and other information regarding issuers, such as we, that file electronically,
with the SEC at www. sec. gov. Our website address is www. alphatau. com. Information contained on, or that can be accessed through, our website
does not constitute a part of this Annual Report and is not incorporated by reference herein. We have included our website address in
this Annual Report solely for informational purposes.

  Business Overview  
 ─────────────────────

We are a clinical